After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...

Colonic air insufflation averaged 30 bulb compressions. Thirty-three patients received IV glucagon (1 mg), and 27 patients did not. The colon was divided into eight segments, and the adequacy of ...

Semaglutide is a glucagon-like peptide-1 receptor agonist ... clinical trials of Ozempic compared once-weekly doses of 0.5 mg and 1 mg for people with type 2 diabetes. When researchers looked ...

Glucagon-like peptide-1 (GLP-1) receptor agonists ... “CagriSema is an investigational fixed-dose combination of a long-acting amylin analogue, cagrilintide 2.4 mg, and semaglutide 2.4 mg. Novo ...

Administration of semaglutide before metabolic and bariatric surgery does not confer benefits for overall weight loss, ...